Radiopharmaceuticals Market (Nuclear Medicine) to witness a healthy CAGR of 5% during the forecast period of 2019 – 2029
Rapid increase in PET and SPECT scanning machines availability is likely to result towards growing demand for radio therapeutics and radio diagnostic events across the globe in the near future. Apart from this, growth in technological improvements with regards to PET scanning devices is expected to further surge the production sales of radiopharmaceuticals across the globe in the coming years. Most importantly, high level of accessibility and awareness has been driving the revenue growth of radiopharmaceuticals market.
A renowned research firm after a thoroughgoing analysis reached on to declare few facts and figures relating to radiopharmaceuticals market. The global market for radiopharmaceuticals is set to witness a healthy CAGR of 5% during the forecast period of 2019 – 2029. Increasing application of nuclear medicine in oncology will garner around half the market value share by the end of 2029. The profiled players that are operating in the radiopharmaceuticals market includes IBA Radiopharma Solutions, Nordion, Inc., GE Healthcare (General Electric Co.), Siemens Healthineers (Siemens AG), Eckert & Ziegler, Lantheus Holdings, Inc. and Advanced Accelerator Applications.
The profiled companies are expected to observe a noteworthy growth in the near future across the globe, which would be beneficial for the overall growth of radiopharmaceuticals market on a larger basis. Manufacturers with the profiled players are seen working keenly on strategic developments that is inclusive of expansion of the product portfolio, innovation as well as advancement of their existing and emerging products, which in due course will help in increasing the customer-base.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1992
IBA Radiopharma Solutions Signs Strategic Contract with AZI
The profiled companies as well as manufacturers can note the point that IBA has recently signed a contract with AZI (Arizona Isotopes Science Research Corp.) for the purpose of installing Cyclone® 70 systems in Arizona, USA. The notable point is that this project has been completely financed and the installation process has been worth around $20Mn. This installation will basically be beneficial for continuous manufacturing of isotopes utilized in cardiovascular diseases diagnosis as well as for various other critical illnesses. Customers must note the point that IBA Radiopharma Solutions has been the only supplier of radiopharmaceutical cyclotrons as it also holds experience and expertise for constructing the existing high energy system.
Heavy investments can be made in IBA Radiopharma Solutions as they can help in attaining the aim of delivering medical isotopes for the purpose of treatment as well as diagnosis of various critical illnesses worldwide.
BWX Technologies, Inc. Plans to Acquire Nordion Medical Isotopes Business of Sotera Health
The profiled companies as well as manufacturers can note the point that BWX Technologies, Inc. has been planning to acquire Nordion medical isotopes business of Sotera Health. This acquisition is for the purpose of de-risking and accelerating the entry of BWX Technologies, Inc. in the medical radioisotope market through addition of licensed infrastructure, two production centers as well as almost 150 highly experienced and trained and personnel. BWX Technologies, Inc. is working towards unique as well as traditional competencies with regards to radiochemical processing for the purpose of expanding high growth potential.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/ask-question/rep-gb-1992
Radiopharmaceuticals Market: Segmentation
- Nuclear Reactors
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Cancer Research Institute
- North America
- Latin America
- Western Europe
- Eastern Europe
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/1992
More From FMI’s Cutting-edge Intelligence:
- Paediatric Vaccine Market Segmentation By Technology – Live Or Attenuated Vaccine, Inactivated Or Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine and Subunit Vaccine; By Indication – Pneumococcal Conjugate Vaccine, DTP Vaccine, Influenza, Meningococcal Vaccine, Polio Vaccine, Rotavirus Vaccine, MMR Vaccine and Varicella Virus Vaccine; By End User – Hospital Pharmacies, Retail Pharmacies and Institutional Health Centres; By Vaccine Type – Monovalent Vaccines and Multivalent Vaccines
- Portable Oxygen Concentrators Market Segmentation By Product – Continuous Flow Portable Oxygen Concentrator and Pulse Flow Portable Oxygen Concentrator, By End User – Hospitals, Homecare, Ambulatory Surgical Centres and Travel Agents
- Peripheral Intravenous Catheter Market Segmentation By Product Type – Short PIVC, Ported PIVC, Non-Ported PIVC and Integrated/Closed PIVC; By Technology – Conventional PIVC and Safety PIVC; By End-User – Hospitals, Ambulatory Surgical Centres, Clinics, Home Use and Others
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org
Press Release Source: https://www.futuremarketinsights.com/press-release/radiopharmaceuticals-market